<DOC>
	<DOCNO>NCT02383654</DOCNO>
	<brief_summary>The purpose study determine safety possible effectiveness Autologous Adipose-Tissue Derived Stem Cells treatment Amyotrophic Lateral Sclerosis ( ALS ) patient .</brief_summary>
	<brief_title>Compassionate Treatment : An Exploratory Clinical Trial Assess Treatment Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description>This pilot clinical trial design see safety possible efficiency ADSCs treatment ALS patient . one subject treat ( n=1 ) . The patient receive brain transplantation ADSCs combine intravenous infusion ADSCs 4 time . Subjects assess adverse effect functional outcome clinical : PI max , PE max , Haloscale respiration , ALS functional rating scale ( ALS-FRS ) analyze 1 month , 3 month , 6 month 9 month 12 month . Brain MRI scan obtain treatment . Long term follow-up perform 1 , 6 , 12months safety reason . Brain CT check operation safety brain implantation . Timing Study : 12months recruitment period approval</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Compassionate Treatment The number participant person . The patient ( Guo XX ) 28 % lung function assessment ( normal lung function great 80 % ) , daily life motor function score 17 point ( normal function score 40 point ) .</criteria>
	<gender>Male</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>Autologous Adipose-Tissue Derived Stem Cells ( ADSCs )</keyword>
</DOC>